Private Advisory Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-16,500
Closed -$7.18M 214
2025
Q1
$7.18M Buy
16,500
+2,114
+15% +$849K 0.8% 39
2024
Q4
$5.31M Buy
+14,386
New +$6.02M 0.59% 48
2023
Q1
Sell
-814
Closed -$418K 210
2022
Q4
$418K Buy
814
+17
+2% +$8.63K 0.09% 142
2022
Q3
$362K Sell
797
-1,477
-65% -$707K 0.08% 135
2022
Q2
$1.1M Buy
+2,274
New +$1.12M 0.25% 77

Other funds holding ELV

Private Advisory Group's ELV Position: Q2 2025 in Review

Private Advisory Group sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 16,500 shares — an estimated $7.18M sold.

Private Advisory Group first reported a position in ELV in Q2 2022 and held it in 5 quarters. The position peaked at $7.18M in Q1 2025. 1,590 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Private Advisory Group reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Private Advisory Group sold 16,500 Elevance Health shares in Q2 2025, an estimated $7.18M.
  • Private Advisory Group first reported a position in Elevance Health in Q2 2022 and held it in 5 quarters.
  • Private Advisory Group's Elevance Health position peaked at $7.18M in Q1 2025.
  • 1,590 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Private Advisory Group's 13F filing for Q2 2025, filed 7 Aug 2025.